| abstract |
The present invention relates to compounds of the Formula (I)n nwherein Q is:n nwhich act as MCH receptor antagonists. These compositions are useful innpharmaceutical compositions whose use includes prophylaxis or treatmentnof improving memory function, sleeping and arousal, anxiety, depression,nmood disorders, seizure, obesity, diabetes, appetite and eatingndisorders, cardiovascular disease, hypertension, dyslipidemia,nmyocardial infarction, binge eating disorders including bulimia,nanorexia, mental disorders including manic depression, schizophrenia,ndelirium, dementia, stress, cognitive disorders, attention deficitndisorder, substance abuse disorders and dyskinesias includingnParkinson's disease, epilepsy, and addiction. |